✦ LIBER ✦

Antioxidant therapy in congestive heart failure: is there any advantage?

✍ Scribed by Pallab K. Ganguly

Book ID: 114742026
Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 329 KB
Volume: 229
Category: Article
ISSN: 0954-6820
DOI: 10.1111/j.1365-2796.1991.tb00333.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ICD's in Congestive Heart Failure—Is The

ICD's in Congestive Heart Failure—Is There Bang for the Beat?

✍ Thomas D. Szucs; Lukas Kappenberger 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 67 KB

Cardia resynchronization therapy outcome

Cardia resynchronization therapy outcomes in congestive heart failure: are there differences in gender?

✍ Lynn G. Tarkington; Salvatore L. Battaglia; April W. Simon; Steven D. Culler; Ed 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Is there a role for calcium channel bloc

Is there a role for calcium channel blockers in congestive heart failure?

✍ Alan B. Miller 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 180 KB

Is there a role for positive inotropic a

Is there a role for positive inotropic agents in congestive heart failure: Focus on mortality

✍ Thomas M. Amidon; William W. Parmley 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 808 KB

Is there a role for warfarin or aspirin

Is there a role for warfarin or aspirin therapy in heart failure?

✍ Syed M. Jafri; John Cleland; Barry Massie 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 597 KB

Despite recent advances in pharmacologic therapy of heart failure, mortality remains high. There is growing evidence that thromboembolic events may contribute to these events. There is evidence for platelet activation, hypercoagulability and endothelial dysfunction in heart failure. The incidence of

Influence of carvedilol on serum digoxin

Influence of carvedilol on serum digoxin levels in heart failure: is there any gender difference?

✍ Nezihi Baris; Sule Kalkan; Sema Güneri; Volkan Bozdemir; Hulya Guven 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 105 KB